Page 2 - Catherinet Doherty News Today

Quest Diagnostics (NYSE:DGX – Get Free Report) issued an update on its FY 2024 earnings guidance on Tuesday morning. The company provided EPS guidance of 8.720-8.970 for the period, compared to the consensus EPS estimate of 8.750. The company issued revenue guidance of $9.4 billion-$9.5 billion, compared to the consensus revenue estimate of $9.4 billion. […]

Scott & Selber Inc. reduced its position in shares of Quest Diagnostics Incorporated (NYSE:DGX – Free Report) by 1.1% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 10,940 shares of the medical research company’s stock after selling 126 shares during […]

Wedge Capital Management L L P NC lowered its position in shares of Quest Diagnostics Incorporated (NYSE:DGX – Free Report) by 4.0% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 239,950 shares of the medical research company’s stock after selling 10,034 shares during the quarter. Wedge […]

Impax Asset Management Group plc trimmed its holdings in Quest Diagnostics Incorporated (NYSE:DGX – Free Report) by 57.4% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 2,592 shares of the medical research company’s stock after selling 3,499 shares during the period. Impax Asset Management […]

Meeder Asset Management Inc. lessened its stake in shares of Quest Diagnostics Incorporated (NYSE:DGX – Free Report) by 24.9% in the fourth quarter, Holdings Channel reports. The institutional investor owned 6,193 shares of the medical research company’s stock after selling 2,054 shares during the quarter. Meeder Asset Management Inc.’s holdings in Quest Diagnostics were worth […]

Olstein Capital Management L.P. lessened its stake in Quest Diagnostics Incorporated (NYSE:DGX – Free Report) by 14.7% during the 4th quarter, Holdings Channel.com reports. The institutional investor owned 58,000 shares of the medical research company’s stock after selling 10,000 shares during the quarter. Olstein Capital Management L.P.’s holdings in Quest Diagnostics were worth $7,997,000 at […]

Boston Trust Walden Corp reduced its stake in shares of Quest Diagnostics Incorporated (NYSE:DGX – Free Report) by 1.4% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 55,165 shares of the medical research company’s stock after selling 795 shares during the quarter. […]

Clean Yield Group increased its holdings in Quest Diagnostics Incorporated (NYSE:DGX – Free Report) by 3.1% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 15,801 shares of the medical research company’s stock after purchasing an additional 475 shares during […]

Quest Diagnostics Incorporated (NYSE:DGX – Get Free Report) has received a consensus rating of “Hold” from the eleven brokerages that are presently covering the company, Marketbeat reports. Nine analysts have rated the stock with a hold rating and two have given a buy rating to the company. The average 12 month price objective among brokers […]

Raymond James Trust N.A. grew its holdings in Quest Diagnostics Incorporated (NYSE:DGX – Free Report) by 45.6% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 2,473 shares of the medical research company’s stock after purchasing an additional 775 shares during the period. Raymond James […]